Newsletters

Pharma execs talk digital therapeutic pricing. Germany reimburses first two prescribable apps.

10.09.20

7 min. Read

Five investors talk digital therapeutics: Red flags, starting up, and COVID–19

10.02.20

14 min. Read

Proteus founders explain. Investors talk DTx.

10.02.20

8 min. Read

Apple eyes asthma, sleep apnea SaMDs? Amwell-Teladongo suit.

9.18.20

8 min. Read

32 Pear patents. Amwell $644M IPO.

9.11.20

6 min. Read

New Teladongo merger details. Pear’s acquisitive study strategy.

9.04.20

8 min. Read

Will Amazon ruin voice biomarkers? Amwell S-1 insights.

8.28.20

8 min. Read

20 percent of Rx-only digital therapeutics have studies so far.

8.14.20

9 min. Read

Nine thoughts on Teladongo. CPT sneak peek.

8.07.20

8 min. Read

Hinge plans virtual MSK clinic. Livongo upping focus on DPP?

7.31.20

5 min. Read